Business
Currency:USD
2024/H1
Stock NameRevenueRatio
Cell therapy280.32M49.93%
生命科学服务及产品217.72M38.78%
Biological preparation development service37.13M6.61%
Industrial synthetic biological products26.11M4.65%
经营管理分部88K0.02%
Product
No Data
Region
Currency:USD
2022/FY
Stock NameRevenueRatio
United States of America.332.1M53.08%
The mainland of China166.75M26.65%
Asia-Pacific region59.01M9.43%
Europe53.28M8.52%
Other14.56M2.33%